Short answer
Moderna (MRNA) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders). Federal district courts designated exclusive forum for Securities Act claims.
Moderna 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Federal district courts designated exclusive forum for Securities Act claims
- Amendment effective May 6, 2026, immediately limiting venue options for shareholder litigation
- Board action responds to recent Delaware corporate-law amendments
- Shareholders may face reduced flexibility in bringing Securities Act lawsuits against Moderna
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Sandra Horning and Abbas Hussain elected as Class II directors through the 2029 annual meeting
- Executive compensation approved, but with 90,761,924 votes against, signaling meaningful shareholder scrutiny
- Annual say-on-pay voting frequency confirmed, increasing recurring accountability for executive compensation
- Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 298,823,277 votes for
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Moderna 8-K filings
Get the next MRNA 8-K as it lands
Follow MRNA for push alerts, or ask the research agent what this filing means.